Clinical Trials Logo

Clinical Trial Summary

The primary objective is to compare the incremental costs (direct and indirect) and benefits (healing outcomes, quality of life) of using foam silver dressing (Mepilex® Ag) to a Silver sulfadiazine 1% cream (Silvadene®) from the perspective of the health care provider.

The secondary objectives are to investigate the safety, the tolerance and the performance on burn status including pain.


Clinical Trial Description

In- and/or out-patients at ten centers in the United States were included in this investigation. Subjects included were 5 years of age and older who suffered from partial thickness burns. Every patient was followed for 3 weeks. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00742183
Study type Interventional
Source Molnlycke Health Care AB
Contact
Status Completed
Phase N/A
Start date August 2008
Completion date November 2009

See also
  Status Clinical Trial Phase
Completed NCT01055587 - Diagnostic of Infections Following Major Abdominal Surgery and Burn Injury N/A
Withdrawn NCT04684121 - Study of the Efficacy and Safety of Granexin® Gel to Improve Burn Wound Healing Phase 2